In a 2022 cosmetic science paper, purified freshwater sponge spicules loaded with a model flavonoid showed very high dermal absorption in ex vivo porcine (pig) skin of 73.4% of the dose in the dermis, while systemic/transdermal passage remained low, indicating that they can act as an effective local dermal delivery system, similar in concept to very superficial microneedling. However, the solid human clinical data are limited to small studies, mostly formula‑specific or manufacturer‑linked. 

One small Korean trial reportedly found better wrinkle/dermal density outcomes when growth factors were combined with spicules versus growth factors alone, but methodology and controls are not robust enough to be definitive. 

The “gimmick” part of spicules comes from mainly from marketing claims which come on top; of dramatic collagen induction, scar removal, or facelift‑like tightening, which are not backed by large, independent, long‑term human trials. Available data suggest modest improvements in texture and radiance at best, mainly by boosting penetration of real actives or mechnical exfoliation by the spicules themselves. When the formula itself is weak (without robust actives) spicules will not compensate. They should be seen as a delivery aid rather than a miracle ingredient.
​
Spicules are cosmetic-grade in EU/Korea (INCI: "Spongilla lacustris Spicule") but lack FDA monograph approval as drugs, limiting claims.​

USER EXPERIENCE

Spicule‑based peels and serums have been used in aesthetic practice for at least one to two decades, with traditional sponge‑powder applications going back much further, and modern K‑beauty “bio‑microneedling” formats expanding rapidly over the past 10–15 years to an estimated nine‑figure USD market, suggesting many millions of units sold worldwide.

Most reported reactions are transient stinging, erythema, tightness, and short‑lived dryness, however the intensity of discomfort depends strongly on spicule length and density: longer and more densely packed spicules create more microchannels and a sharper, more aggressive feel, whereas shorter or lower‑density systems are better tolerated. Subjectively, many users describe the sensation as similar to handling fiberglass or prickly pear spines; sharp, prickly, and aggravating rather than a mild “tingle” with this perception increasing as spicule size and concentration rise. Patting rather than rubbing tends to reduce discomfort while still providing a penetration benefit, so application technique is important for tolerability. Given the current lack of robust long‑term human safety data, spicule products are generally not ideal for very sensitive, rosacea‑prone, or barrier‑impaired skin, and high‑frequency use in these groups should be approached with caution.

SPICULE LENGHT
Most commonly spicules measure 100–300 μm in length, determining their skin penetration depth:

▌~100 μm: Superficial penetration, targeting the stratum corneum for very gentle exfoliation and enhanced absorption, suitable for regular at-home use
▌~300 μm: Deeper but still epidermal penetration, however still less deep compared to microneedling

Therefore, when you see 100 or 300 related to spicules, it’s a reference to their physical size and penetration depth, which determines their strength and function in skincare routines. This shallow range (100–300 μm) creates microchannels to enhance active absorption without reaching the dermis or causing significant trauma/downtime. Some brands like Mediheal and ClearDea use a very short spicules, which are more gentle, however also less effective as active penetration enhancers.

Classic microneedling needles penetrate from about 0.25 mm (250 μm) to 2.5 mm (2500 μm), much deeper than spicules. 

TYPES OF MICRONEEDLE TECHNOLOGIES – COMPARISON FROM MANUFACTURER

SPICULE CONCENTRATION CONFUSION

VT Reedle Shot, comes in various spicule concentrations (e.g., 50, 100, 300, 700), where higher numbers mean stronger micro-needling/exfoliation effects due to higher spicule density, not necessarily larger spicule size. Users report that higher concentrations like 300 or 700 have stronger exfoliating and penetrating sensations, while lower concentrations like 50 or 100 are milder. These concentration differences affect the intensity of the delivery effect and potential skin irritation. Higher concentrations create more microchannels but may increase tingling or prickling sensations and require less frequent use. Lower concentrations are gentler and can be used more regularly and are more suitable for sensitive or irritable skin.

VT describes its Cica Reedle™ spicules as “around fourteen times thinner than pores” and “smaller than pores,” without disclosing an exact micrometer size; typical facial pores are on the order of 200–300 µm in diameter, so this implies a very fine needle‑like structure. For Reedle Shot 300, VT and retailers report approximately 237,500 Cica Reedles per application, which, together with Cica Reedle’s small diameter, helps explain the pronounced “liquid microneedling” sensation and improved absorption, texture, pore visibility, and acne‑related roughness noted in marketing and user feedback. Classic Reedle Shot formulas pair Cica Reedle™ with Centella asiatica, multi‑weight hyaluronic acid, niacinamide, adenosine, propolis, and amino acids (CICA‑HYALON™ complex) for soothing, barrier support, and slow‑aging benefits. The Reti‑A Reedle Shot variants add a vitamin A complex (retinol and retinoid ester) plus bakuchiol on top of the Cica Reedle™ system, using the spicules to enhance retinoid delivery while the CICA‑HYALON™ base supports tolerability.

SPICULES + EXOSOMES
​
Medicube 1-Day Exosome Shot which is marketed as “microneedling in a bottle,” is available in 7,500 and 2,000 “microneedle” versions. 
▌7,500 spicules = Total hydrolysed sponge spicules delivered in one full application of the 7,500 version (typically 30ml bottle or single-use ampoule equivalent).
▌2,000 spicules = Total in the milder 2,000 version per application.
These are density/concentration markers for marketing and product differentiation. Key difference between both brands mentioned is that VT uses relative concentration (spicules/ml), while Medicube uses absolute count per treatment. Both scale intensity with higher numbers, but Medicube's 7,500 delivers far more spicules total despite similar density effects.

PAINLESS SPICULES
ClearDea is a brand that uses Collanetinal™ spicules of approximately 0.01 mm (11 μm) in length, i.e., very short. Because spicule length largely determines penetration depth, these collagen‑ and retinol‑coated spicules are expected to act predominantly in the very superficial layer(s) of the skin and to be gentler than longer, more prickling spicules. They are likely to be less efficient as active delivery enhancers. ​

SPICULES + CAPSULSES
​
In the SUNGBOON EDITOR gel‑cream, (tiny whitish) spicules are combined with separate capsules containing very low molecular weight (200 Da) collagen‑related ingredients, retinol, niacinamide, hyaluronic acid and panthenol in a gel-base. Spicules are designed to boost the bioavailability of the encapsulated actives by nudging them closer to the viable epidermis and superficial dermis, which may enhance visible results compared with a conventional cream of similar composition. The magnitude of this benefit, however, is tightly linked to spicule size (not disclosed for this product) and density. The formula contains 300.000 shots, which is a marketing way of saying that one jar contains approximately 300,000 individual spicules. The prickly, tingling feel from the spicules is frequently mentioned in reviews; some users enjoy it as a sign that the product is “doing something,” while others find it uncomfortable or briefly stinging. SUNGBOON recommends specifically for dry skin 2 part capsuls and 1 part gel, for oily skin 2 parts gel and 1 part capsule and for combination skin 1 part capsule and 1 part gel ratio.

​The concentration of active ingredients:
▌200 Da collagen: 1,100,000 ppb, which literally means 1,100,000 parts of a substance in 1,000,000,000 parts of the total mixture. In percentage terms, that is 0.11%. 
▌Niacinamide: 20,000,000 ÷ 1,000,000,000 = 0.02, which corresponds to 2%.
▌Retinol: 3000 ppb is 0.0003%. 
Retinol at just 0.0003% (3 ppm) barely penetrates skin: less than 1% gets through without help. Spicules' microchannels boost this 10x or more, making tiny doses far more effective. 

If SUNGBOON´S before‑and‑after photos truly reflect typical results, this product would be worth serious consideration. However, when used consistently and with appropriate skin tolerance, SUNGBOON EDITOR Deep Collagen Retinol can realistically be expected to modestly improve skin smoothness, hydration and fine lines rather than produce dramatic “filler‑like” changes. Some users experience more bouncy or firmer skin and even skin tone.

Similar, however not the same is the VT Reedle Shot 2‑step masks, which are bio‑microneedling sheet masks that combine a spicule “essence” with an occlusive mask to intensify penetration and skin benefits. In step 1, a concentrated ampoule containing natural micro‑spicules (Cica Reedle™ based on silica and Centella) is massaged onto cleansed skin, creating temporary microchannels and a characteristic tingling or prickling sensation while priming the surface.

Step 2 is a serum‑soaked sheet mask placed over this prepped skin for 15–30 minutes; it is typically loaded with humectants and barrier‑supporting actives such as hyaluronic acid, hydrolyzed collagen, peptides, niacinamide, centella, propolis, and amino acids, aiming to hydrate, improve elasticity, refine texture, and calm irritation.  Different versions (e.g., Mild 50, 100, 300) reflect increasing spicule density and intensity: lower numbers are gentler and better suited to sensitive or first‑time users, while higher numbers are positioned for concerns like rough texture, post‑acne marks, dullness, and fine lines, used no more than 1–2 times per week.

​Glutathione Vita Glow Spicule Shot
▌Focuses on radiance and tone uniformity, pairing 2,000 ppm glutathione with vitamin C derivatives in a spicule delivery base.
▌The spicule system provides a “microneedling effect” with tingling/micro‑stimulation while driving antioxidants deeper to enhance glow and transparency.
▌Clinical testing is claimed for improvements in brightness and overall skin tone.

Across these products, Genabelle positions spicules as an at‑home, low‑downtime alternative to procedural microneedling, designed mainly to boost delivery of brightening/antioxidant complexes while also addressing texture and early signs of aging, with suitability claims extending even to drier or more sensitive skin types but still with expected tingling on use.

SPICULES + PEPTIDES
Several brands deliberately pair peptides-molecules that typically show poor passive skin penetration with spicule‑based ‘bio‑microneedling’ systems, leveraging the micro‑channels created by spicules to substantially enhance peptide delivery into deeper epidermal and dermal layers, as proven by spicule‑based peptide delivery studies.

In a 2021 study, sponge spicules from Haliclona sp. (SHS) were incorporated into topical formulations containing insulin (hydrophilic peptide) and cyclosporine A (hydrophobic cyclic peptide). SHS increased insulin transdermal flux from 5.0 ± 2.2 ng/cm²/h (passive) to 457.0 ± 32.3 ng/cm²/h (about 90‑fold) and raised its deposition in deeper skin layers from 0.6% to roughly 55%. This enhancement was both spicule‑dose‑dependent and peptide‑dose‑dependent, supporting a true mechanistic effect of the spicules on peptide penetration.

DR.PEPTI Peptide Spicule Pore Solution Serum contains Hydrolyzed Sponge (3,000 ppm) as the spicule source plus an extensive peptide complex: acetyl hexapeptide‑8, acetyl octapeptide‑3, multiple tetra‑, tri‑, and dipeptides, copper tripeptide‑1, palmitoyl peptides, etc., alongside retinol, exosomes, bakuchiol, glutathione, tranexamic acid and sodium DNA. It is positioned for pore care, elasticity and anti‑aging, using spicules to drive the peptide blend deeper.

TONYMOLY Peptide Spicule Firming Ampoule  is described as an elasticity ampoule with peptide + bakuchiol + collagen‑coated spicules for firming sagging skin and fine lines. Here the spicules are directly linked to both collagen and peptide‑driven firming.

ALTUM™ PEPTIDE / PEPTAXEL™ programs (Skinzzo LAB) is a professional bio‑microneedling system where Raphitox™ spicules are bound to tripeptides, then released in the epidermis via glutathione; positioned as “5th‑generation spicules” specifically designed to deliver peptides for collagen stimulation. Altum™ Peptide (Raphitox‑bound tripeptides) compared a peptide‑only cream vs. spicules + peptides vs. Altum’s peptide‑spicule complex; the “spicules + peptides” combo outperforms peptides alone in improving skin density and wrinkles, supporting the delivery advantage.
​
Spicule Serum concept formulas (CTK): OEM “Spicule Serum” bases combine spicules + a 10‑peptide complex + collagen complex + panthenol, marketed for elasticity, lifting and hydration.

SOME NOTEWORTHY LESSER KNOWN BRANDS WHICH INCORPORATED SPICULE DELIVERY SYSTEMS:

▌Pepticule pairs spicules with acetyl hexapeptide-8 for “botulinumtoxin-like”anti-wrinkle effects via deep delivery. 
▌Pestlo Spicule Reborn Peeling Mask combines spicules with green tea and mugwort for brightening and even tone.
▌9wishes Pine Perfect Ampule Serum uses spicules alongside pine, licorice, and green tea extracts to target acne and renewal.
▌Isomers Diamond Peptide Spicule Body Cream blends spicules, diamond powder, alp rose stem cells, caffeine, and peptides to address body stretch marks, sagging, and texture.

REPRESENTATIVE SPICULE SKINCARE PRODUCTS OVERVIEW

VERDICT

“Do spicules work?”: yes, as a micro‑delivery technology, there is evidence that spicules enhance dermal delivery and can improve clinical skin parameters when paired with effective actives and when spicule length and density are sufficient. They likely also provide to some degree of mechanical exfoliation on application. Studies indicate that spicules can also help larger molecules, such as peptides and other macromolecules that usually penetrate the skin poorly in standard skincare, reach deeper skin layers more effectively when they are formulated together. 

“Are spicules a miracle?”: no; current scientific evidence is sparse, short‑term, and often industry‑linked, so they should be viewed as an adjunct delivery tool with potential, not a stand‑alone, clinically proven game‑changer. 

Worth a try”?: Alternative, more controlled options exist (e.g., microneedling, microstamping) that can provide similar or superior penetration or textural benefits without persistent mineral needles in the skin. Products containing “longer” spicules are potentially worth trying only for people with very resilient skin who are highly motivated and comfortable with discomfort and some uncertainty. For sensitive skin or risk-averse users, maybe the very short coated spicules are an option.

​Personally, I would recommend spicule‑based products only with caution at this stage, and limit use to a single product at a time whose active ingredients clearly match your main skin need r concern. The technology is exciting and promising, however more robust human safety data are needed before fully endorsing it, even though there is roughly 10–15 years of user experience without serious adverse effects reported. Daily use is not advisable. Spicules persist in the skin up to 72 hours, with no data on long-term accumulation, which could theoretically trigger granuloma formation from silica persistence as biogenic spicules may trigger foreign body reactions in long-term use, cause subclinical inflammation, or barrier impairment, changes that ultimately accelerate skin ageing.

Take care!
Anne-Marie

REFERENCES

▌Kim TG, Lee Y, Kim MS, Lim J. A novel dermal delivery system using natural spicules for cosmetics and therapeutics. J Cosmet Dermatol. 2022 Oct;21(10):4754-4764. doi: 10.1111/jocd.14771. Epub 2022 Feb 1. PMID: 35034416. 
▌Ha JM, Lim CA, Han K, Ha JC, Lee HE, Lee Y, Seo YJ, Kim CD, Lee JH, Im M. The Effect of Micro-Spicule Containing Epidermal Growth Factor on Periocular Wrinkles. Ann Dermatol. 2017 Apr;29(2):187-193. doi: 10.5021/ad.2017.29.2.187. Epub 2017 Mar 24. Erratum in: Ann Dermatol. 2017 Dec;29(6):828. PMID: 28392646; PMCID: PMC5383744.
▌Kim, H., Lee, H. J., Lee, H., Kim, S. N., & Park, E. S. (2021). Enhanced skin delivery of therapeutic peptides using sponge spicules in combination with flexible liposomes. Biomolecules & Therapeutics, 29(6), 707–716. https://doi.org/10.4062/biomolther.2021.166
▌Lee, N.E.; Kim, J.E.; Bang, C.Y.; Bang, O.Y. Nano-Encapsulated Spicule System Enhances Delivery of Wharton’s Jelly MSC Secretome and Promotes Skin Rejuvenation: Preclinical and Clinical Evaluation. Int. J. Mol. Sci. 2025, 26, 10024. https://doi.org/10.3390/ijms262010024
▌Udompataikul, M., Wongniraspai, M., Showpittapornchai, U., & Jariyapongsakul, A. (Year). The study on effects and safety of Spongilla lacustris in 3% hydrogen peroxide solution on rat skin. Journal Name, Volume(Issue), pages.
▌The Ultimate Guide To Spicules SkinCare: A Revolutionary Approach To Skincare https://spongespicule.com/the-ultimate-guide-to-spicule-skincare/

This post is based on my own, independently purchased products and personal research. It is intended for educational and informational purposes only, does not replace individual medical advice, and is not intended to diagnose, treat, cure, or prevent any disease. All opinions are my own; this content is not sponsored, and no affiliate links are used.

Facial blushing is fairly common and an involuntary reddening of the face oftentimes triggered by embarrassment or stress [1][2]. It can be a distressing experience, disrupting social interactions and impacting self-confidence. While you're engaged in a pleasant conversation, an unexpected surge of warmth floods your face, causing visible redness that feels impossible to control. It can lead to embarrassment and a desire to find effective ways to manage or prevent such episodes.
 
Excessive facial flushing is more than just a cosmetic concern; significantly affecting one's quality of life and social interactions. While surgical intervention exist and effective, they often come with high costs and potential risks. Fortunately, there is a range of less invasive approaches to manage this condition.
 
SYMPTOMS
Severe facial blushing is often associated with social anxiety disorder (SAD), can manifest through various physiological and psychological symptoms:
 
1. Intense reddening of the face, neck, and chest [3][4]
2. Sensation of heat or warmth in the affected areas [4]
3. Increased blood flow to facial blood vessels [3][5]
4. Elevated skin temperature in the face [3]
5. Perspiration, particularly in the face and palms [6]
6. Increased heart rate and blood pressure [6]
7. Feelings of embarrassment or self-consciousness [3][4]
8. Avoidance of social situations or eye contact [4][7]
9. Heightened awareness of one's own blushing [3][8]
10. Persistent worry about blushing in social situations [7][8]
 
UNDERSTANDING FACIAL FLUSHING
The face has more capillary loops per unit area and generally more vessels per unit volume than other skin areas. Blood vessels in the cheeks are wider in diameter and closer to the surface.
 
There are several factors contributing to blushing or flushing:
1. Neurovascular dysregulation: Research suggests that individuals prone to facial flushing may have heightened sensitivity in the neural pathways controlling blood flow to the face [9].
2. Genetic predisposition: A study published in Nature Genetics (2015) [10] identified genetic variants associated with rosacea, a condition often characterized by facial flushing.
3. Environmental triggers: Factors such as temperature changes, spicy foods, alcohol, emotional stress and exercise can exacerbate flushing [11].
4. Underlying medical conditions: In some cases, facial flushing may be a symptom of conditions like rosacea, menopause, carcinoid syndrome or hyperthyroidism [12].
5. Certain medications for diabetes, bloodpressure or cholesterol can excercabate flushing.
 
The blushing response is primarily mediated by the sympathetic nervous system. When triggered by social stimuli or self-conscious emotions, facial blood vessels dilate (expand), increasing blood flow to the skin [3][5]. This process is regulated by beta-adrenergic sympathetic nerves, which are responsible for the dilation of blood vessels in the face [6].

​MENOPAUSE
Facial flushing is a common symptom experienced by women during menopause, often associated with hot flashes. This is primarily attributed to hormonal changes, particularly the decline in estrogen levels.
 
1. Prevalence: Approximately 75% of perimenopausal and menopausal women experience flushing [13].
2. Mechanism: Flushing occurs due to vasodilation of dermal and subcutaneous blood vessels, likely caused by the loss of peripheral vascular control associated with estrogen deficiency [13].
3. Duration: Hot flashes, including facial flushing, can persist for years after menopause. Among women 5-9 years postmenopausal, over 20% still report clinically significant hot flashes [14].
4. Associated symptoms: Flushing is often accompanied by sensations of heat, sweating, anxiety, and chills [15].
5. Impact on skin: Menopausal hormonal changes affect the skin barrier, making it more sensitive and vulnerable to irritation [16].
6. Treatment: Estrogen therapy is generally effective in managing menopausal flushing [13]. However, for women who cannot use estrogen, alternative treatments are necessary [17]. (See also point 11 HRT at the end)
7. Persistence: In a study of women with significant hot flashes at baseline, 50% reported unchanged or worsened symptoms after 3 years [14].
8. Risk factors: Women who are more recently menopausal, have previously used estrogen, or have undergone hysterectomy are more likely to experience persistent hot flashes [14].
 
DIFFERENCE BETWEEN BLUSHING AND FLUSHING
While the terms 'blushing' and 'flushing' are sometimes used interchangeably, they can be distinguished based on their triggers. Blushing is typically associated with emotional responses, while flushing may have various physiological causes. Severe cases of facial blushing are known as idiopathic cranio-facial erythema [18][19].
 
Two types of blushing have been identified:
1. Wet blushing is associated with increased perspiration. This type is believed to result from an overactive sympathetic nervous system [20], which regulates various bodily functions, including the dilation of facial blood vessels. In some people, these nerves exhibit heightened sensitivity to emotional stress [21]. 
The blushing response is primarily mediated by the sympathetic nervous system. When triggered by social stimuli or self-conscious emotions, facial blood vessels dilate, increasing blood flow to the skin [3][5], resulting in visible reddening [22][23].  This reaction can extend to the ears, neck, and chest.
 
Mellander et al. discovered that facial veins possess unique characteristics, including beta-adrenoceptors or beta-adrenergic sympathetic nerves, responsible for the dilation of blood vessels in the face, in addition to alpha-adrenoceptors, which may contribute to emotional blushing [6][24].
 
2. Dry flushing is a form of flushing caused by circulating vasodilating mediators in the bloodstream and does not involve increased perspiration [19][20]. These mediators can be either exogenous (from ingested substances) or endogenous (associated with systemic disorders). This type of flushing is also referred to as "vasodilator-mediated flushing" and is distinct from autonomic neural-mediated flushing, which typically involves sweating [20].
 
PSYCHOLOGICAL IMPACT
Blushing may serve a regulatory role in social interactions, potentially mitigating incidents that could spark social conflicts. It signals awareness of social transgressions and may elicit more sympathetic responses from others [25][26].
 
Severe blushing can significantly impact an individual's quality of life [23], even lead to social anxiety and avoidance behaviours [7][8]. The fear of blushing itself known as erythrophobia can exacerbate the condition, creating a cycle of anxiety and increased blushing propensity [4][8].
 
Severe facial blushing is a common symptom of social anxiety disorder (formerly known as social phobia), characterized by intense fear of social situations and negative evaluation [23]. People with this disorder often experience heightened self-conscious emotional reactivity, with blushing being a core physiological symptom [3].
 
MEASUREMENT AND ASSESSMENT

Blushing can be assessed through various methods:

▌Self-report measures, such as the Blushing Propensity Scale [4][8]
Blushing Propensity Scale (Leary & Meadows, 1991) 
Indicate how often you feel yourself blush in each of the following situations using the scale below: 
 
1 = I NEVER feel myself blush in this situation.
2 = I RARELY feel myself blush in this situation.
3 = I OCCASIONALLY feel myself blush in this situation. 
4 = I OFTEN feel myself blush in this situation.
5 = I ALWAYS feel myself blush in this situation. 
 
____  1. When a teacher calls on me in class
____  2. When talking to someone about a personal topic
____  3. When I'm embarrassed
____  4. When I'm introduced to someone I don't know
____  5. When I've been caught doing something improper or shameful
____  6. When I'm the center of attention
____  7. When a group of people sings "Happy Birthday" to me
____  8. When I'm around someone I want to impress
____  9. When talking to a teacher or boss
____  10. When speaking in front of a group of people
____  11. When someone looks me right in the eye
____  12. When someone pays me a compliment
____  13. When I've looked stupid or incompetent in front of others
____  14. When I'm talking to a member of the other sex
 
The total score is obtained by summing the ratings across all items. 
For example:
Low blushing propensity scores ranged from 3-17, with a mean of 11.4
High blushing propensity scores ranged from 40-63, with a mean of 51.3
 
▌ Physiological measurements of blood flow and skin temperature [3][5]
▌ Observational assessments by trained raters [8]
 
Research has shown that the relationship between blushing and social anxiety is strong for self-perceived blushing, small for physiological blushing, and medium for observed blushing [8].
 
MANAGEMENT STRATEGIES 
It´s important to understand why this is happening to you and address contributing factors or triggers. Persistent or severe facial flushing should be evaluated by a dermatologist, as it may be a symptom of underlying conditions like for example rosacea [27], especially when accompanied by other symptoms. 
 
1. Topical treatments: 
▌Brimonidine gel (Mirvaso®) has shown efficacy in reducing facial erythema in rosacea patients [28] and might help to reduce redness from facial flushing.
▌Oxymetazoline cream (Rhofade®) is another FDA-approved topical treatment for persistent facial erythema [29].
 
2. Oral medications:
▌Low-dose oral beta-blockers, such as propranolol, have demonstrated effectiveness in reducing blushing and flushing [30].
▌Clonidine (antihypertensive), is a centrally acting alpha-adrenergic agonist, has shown mixed results in treating some types of flushing, with positive results in menopausal women. However it failed to reduce flushing provoked by red wine, chocolate, and hot weather in rosacea studies or in rosacea patients. [31].
 
3. Laser and light therapies:
▌Pulsed dye laser and intense pulsed light treatments can help reduce visible blood vessels and overall redness [32].
 
4. Cognitive Behavioral Therapy (CBT):
▌CBT has shown promise in helping individuals manage the psychological aspects of blushing and reduce its frequency [33].
 
5. Skincare routine and lifestyle modifications:
▌By simplifying your routine, use gentle, non-irritating skincare products, daily (tinted) broadspectrum sunscreen and avoid known triggers can help manage symptoms [34]. 
▌Regular exercise and stress-reduction techniques like meditation may help regulate the body's response to flushing triggers [35].
 
6. Dietary adjustments:
▌Reducing intake of spicy foods, alcohol, and hot beverages may help [11].
 
7. Botulinum Toxin injections:
▌Small doses of botulinum toxin have shown potential in reducing facial flushing in some studies [36].
 
8. Vasoconstriction can help against facial flushing, and there are several methods to achieve this effect using topical ingredients and cooling techniques:
▌Topical vasoconstrictors:
Oxymetazoline, an alpha-adrenergic agonist, has shown effectiveness in reducing facial redness and flushing associated with rosacea by constricting blood vessels when applied topically [37]. This ingredient is available in some countries as a prescription cream under the brand name Rhofade.
The active compound in Visine eye drops, tetrahydrozoline hydrochloride, is a vasoconstrictor that constricts blood vessels to reduce redness [38]. While primarily used for eye redness, it may potentially help with facial flushing due to its vasoconstrictive properties. Visine is not approved, specifically researched or recommended for use on facial skin [38], however might give a very temporary positive effect. Be aware that prolonged use of vasoconstrictors like tetrahydrozoline can lead to rebound dilation of blood vessels, potentially worsening redness over time [38].
▌Cooling therapies:
Cooling skin to 10–20°C rapidly induces cutaneous vasoconstriction through both sympathetic nerve activation and direct vascular smooth muscle effects, cutting facial blood flow by 40–60% within 2–5 minutes—with vasoconstriction persisting 10–20 minutes after cooling ends . This makes localized cooling highly effective for acute facial flushing management [39]. 
▌Thermoelectric cooling devices: A personal favourite device of mine is the Therabody TheraFace Depuffing Wand. It uses thermoelectric (Peltier) cooling technology, often branded as "Cryothermal Technology."​ This allows it to actively cool to 10–14°C (50–57°F) and heat to 35–42°C (95–108°F) within seconds without refrigeration or external heat sources. A study using such a device demonstrated that skin cooling produced a significant reduction in cutaneous vascular conductance (CVC) that persisted even after the active cooling period [40]. 

▌Skincare ingredients:
Caffeine is found in many creams and serums, has anti-inflammatory properties and constricts microcapillaries (bloodvessels). This might eliviate the redness temporarily, however can cause irritation in higher concentrations, especially in sensitive skin.
While not directly causing vasoconstriction, certain skincare ingredients can help manage facial redness:
Silymarin, a compound derived from milk thistle has demonstrated potential benefits. A double-blind, placebo-controlled study found that a topical treatment combining silymarin and methylsulfonylmethane was particularly effective for rosacea subtype 1, which is characterized by facial flushing and persistent redness [41]. Silymarin's has anti-inflammatory and antioxidant properties, which help modulate cytokines and angiokines involved in skin redness [42]. A systematic review of polyphenols (including silymarin) in rosacea treatment found evidence that these compounds may be beneficial, especially in reducing facial erythema [42], confirmed by in vivo by studies I´ve done myself on patients with couperose and ageing related facial redness [43]. We´ve proven Silymarin´s effect on improving skin´s microcirculation and microcapillaries including strenghtening of microcapillary walls.
Licochalcone A works as a powerful anti-oxidant has anti-ínflammatory properties and proven to significantly improve redness, including in patients with rosacea and couperose [43].
Menthoxypropanediol (MPD) is a synthetic derivative of menthol that can be beneficial for reducing skin redness. MPD provides a cooling sensation when applied to the skin, which can help soothe irritated and red skin, however particurlarly effective I relieve from itch associated with atopic dermatitis [44].
Niacinamide: Topical niacinamide (nicotinamide) does down‑regulate several inflammatory cytokines, improves barrier function and TEWL, and has some evidence for reducing erythema in rosacea/sensitive skin, but it is not a dedicated anti‑flushing vasomodulator. Its main relevance for facial flushing is indirect: reducing background inflammation, improving barrier integrity, and possibly lowering trigger sensitivity over time. Most controlled safety data show good tolerance up to 10%, yet case reports and expert reviews note that some sensitive individuals experience flushing, stinging and burning even within this range. 
Azelaic acid has FDA approval for rosacea at a 15% concentration in topical prescription products for the treatment of inflammatory papules and pustules of mild to moderate papulopustular rosacea. Azelaic acid at 15% reduces rosacea‑related redness mainly by dampening the abnormal inflammatory cascade in skin, rather than by directly constricting blood vessels. It improves erythema scores in papulopustular rosacea by decreasing cathelicidin/LL‑37 and kallikrein‑5 activity and lowering pro‑inflammatory mediators, which reduces the inflammatory component of flushing‑type redness over time.
Madecassoside / Asiaticoside (Centella asiatica): Madecassoside inhibits pro-inflammatory cytokines (IL-1β), NF-κB nuclear translocation, and TLR2 expression in stimulated monocytic cells, supporting reduced inflammation that could indirectly lower redness triggers. Asiaticoside and madecassoside promote collagen synthesis and wound healing via TGF-β/Smad signaling, with barrier repair inferred from increased aquaporin-3, loricrin, involucrin, and hyaluronan in keratinocytes, potentially reducing sensitivity to flushing precipitants.
Allantion: Allantoin demonstrates soothing and barrier-protective effects in peer-reviewed safety assessments, with mild anti-irritant activity via keratolytic and moisturing mechanisms, but no specific RCTs confirm efficacy for flushing-related redness reduction.
  
There are more “anti-redness” ingredients available in skincare products, usually tested and suitable for rosacea or couperose prone skin, thus unfortunately not specifically intended to improve blushing or flushing. Most are suitable as adjuncts, rather than primary standalone options.
 
9. Color cosmetics and skincare: Foundation or skincare products containing colour pigments unify the skin tone and can help to cancel out some of the redness.
 
10. Surgery: Endoscopic thoracic sympathectomy (ETS) is an operation to treat severe facial blushing, performed under general anesthesia as a last resort when other treatments have failed. 
 
The cure rate for facial blushing with ETS is high, but varies across studies. A case series of 831 patients reported a mean symptom improvement score decrease from 9 to 3 (on a 10-point scale) at 29 months follow-up, which was statistically significant (p<0.0001) [45]. Another study found that 85% of 244 patients with facial blushing reported being "totally satisfied" at a mean follow-up of 8 months [45].
 
While initial results are often positive, long-term outcomes may vary. A study with a median follow-up of 19.6 months found that complete resolution of blushing was achieved in 48% of patients, with significant differences based on the type of blushing (emotional: 55%, thermoregulatory: 28%, constant: 15%, P = .03) [46]. The most common side effect is compensatory sweating, reported in up to 90% of patients [47]. In a long-term follow-up study, 6.3% of patients who had ETS for hyperhidrosis regretted having the operation [48]. Thus, while ETS can be effective for many patients with severe facial blushing, it's crucial to carefully consider the potential risks and long-term outcomes before proceeding with this invasive treatment.
 
11. Hormone replacement therapy
HRT can effectively reduce facial flushing in menopausal women. HRT is highly effective in alleviating hot flushes and night sweats, which are common vasomotor symptoms experienced during menopause [52][53]. These symptoms often manifest as facial flushing.
▌HRT significantly reduces the frequency of hot flushes compared to placebo, with a 77% reduction in frequency observed in clinical trials [52].
▌The severity of vasomotor symptoms, including facial flushing, is also significantly reduced with HRT compared to placebo [2]. The benefits of HRT in reducing vasomotor symptoms are often seen within a few weeks of starting treatment [54].
▌Estrogen, a key component of HRT, helps regulate vascular function. During menopause, the decline in estrogen levels can lead to increased blood flow and dilated blood vessels, potentially worsening flushing. HRT can help stabilize these hormone levels.
 
It's important to note that while HRT is effective, it does come with potential risks and benefits that should be discussed with a healthcare provider to determine if it's the right treatment option for an individual.
 
PREVALENCE
In a study of patients undergoing anesthesia, 47% of women and 33% of men reported blushing easily [49]. Blushing is (more) common in young people and women [49]. In a surgical study for facial blushing treatment, 82% of patients had emotional blushing, 58% had thermoregulatory blushing, and 32% had constant blushing [50]. While these figures don't provide a definitive prevalence for the general population, they suggest that facial blushing and flushing are relatively common, especially among those with social anxiety disorders where blushing is reported to affect up to 50% of patients [51].
 
Always partner with your dermatologist for personalised diagnosis and guidance.
 
Take care
Anne-Marie
 
References:
[1] Ioannou S, et al. Front Hum Neurosci. 2017;11:525.
[2] Thorstenson CA, et al. Cognition and Emotion. 2019;34(3):413-426.
[3] Nikolić M, et al. J Child Psychol Psychiatry. 2020;61(12):1339-1348.
[4] Su D, Drummond PD. Clin Psychol Psychother. 2011;19(6):488-495.
[5] Ishikawa N, et al. Front Psychol. 2023;14:1259928.
[6] Jadresic E. Medwave. 2016;16(6):e6490.
[7] Kristian S, Christer D. Thorac Surg Clin. 2016;26(4):459-463.
[8] Nikolić M, et al. Clin Psychol Sci Pract. 2015;22(2):177-193.
[9] Mikkelsen CS, et al. J Clin Exp Dermatol Res. 2016;7(2). 
[10] Nature Genetics. (2015). 47(12), 1449-1452.
[11] Weinkle, A. P., et al. (2015). Journal of Clinical & Aesthetic Dermatology, 8(8), 37–42.
[12] Huynh, T. T. (2013). American Family Physician, 87(9), 638-644.
[13] Kamp E, et al. Clin Exp Dermatol. 2022;47(12):2117-2122.
[14] Huang AJ, et al. Arch Intern Med. 2008;168(8):840-846.
[15] Bansal R, Aggarwal N. J Midlife Health. 2019;10(1):6-13.
[16] Rajab F. Dermatology Times. 2023;44(02).
[17] Sassarini J, Anderson RA. Lancet. 2017;389(10081):1775-1777.
[18] Wilkin JK. J Am Acad Dermatol. 1988;19(2 Pt 1):309-131. 
[19] Wilkin JK. Clin Dermatol. 1993;11(2):211-231.
[20] Rastogi V, et al. Clin Med Res. 2018;16(1-2):16-28.
[21] Cutlip WD, Leary MR. Behav Neurol. 1993;6(4):181-5.
[22] Gerlach AL, et al. J Abnorm Psychol. 2001;110(2):247-58. 
[23] Social Anxiety Alliance UK. (n.d.). Blushing and Social Anxiety. 
[24] Mellander S, et al. Acta Physiol Scand. 1982;114(3):393-399.
[25] Anthroinpractice. Anthropology in Practice. 2011.
[26] Thorstenson CA, et al. Cognition and Emotion. 2019;34(3):1-14.
[27] Better Health Channel. (n.d.). Blushing and flushing. 
[28] Fowler, J., et al. (2013). Journal of Drugs in Dermatology, 12(6), 650-656.
[29] Baumann, L., et al. (2018). Journal of Drugs in Dermatology, 17(1), 97-105.
[30] Drott, C., et al. (2002). Annals of Surgery, 236(2), 155-162.
[31] Wilkin JK. Arch Dermatol. 1983;119(3):211-214.
[32] Wat, H., et al. (2014). Journal of Cutaneous and Aesthetic Surgery, 7(2), 73–80.
[33] Zou, J. B., et al. (2016). Behaviour Research and Therapy, 77, 86-97.
[34] Del Rosso, J. Q., et al. (2017). Journal of Clinical and Aesthetic Dermatology, 10(6), 37-46.
[35] Egeberg, A., et al. (2017). British Journal of Dermatology, 176(3), 591-600.
[36] Park, K. Y., et al. (2013). Dermatologic Surgery, 39(3pt1), 419-424.
[37] Skin Plus Pharmacy. (n.d.). Topical Oxymetazoline for Rosacea.
[38] Wikipedia contributors. (n.d.). Visine. Wikipedia.
[39] Khoshnevis S, et al. J Biomech Eng. 2016;138(3):4032126.
[40] Mejia N, et al. J Med Device. 2015;9(4):0445021-445026.
[41] Berardesca E, et al. J Cosmet Dermatol. 2008;7(1):8-14.
[42] Saric S, et al. J Altern Complement Med. 2017;23(12):920-929.
[43] Van Geloven A, et al. EADV 2016 P2194.
[44] Weber TM, et al. J Cosmet Dermatol. 2006;5(3):227-32.
[45] NICE. (2014). Endoscopic thoracic sympathectomy for primary facial blushing. Interventional procedures guidance [IPG480]. 
[46] Park JK, et al. Medicine. 2022;101(27):e29808.
[47] Malmivaara A, et al. Int J Technol Assess Health Care. 2007;23(1):54-62. 
[48] Gossot D, et al. Ann Thorac Surg. 2003;75(4):1075-9.
[49] Olday J, et al. Anaesthesia. 2003;58(3):275-7.
[50] Park JK, et al. Medicine (Baltimore). 2022;101(27):e29808.
[51] Callejas MA, et al. Actas Dermosifiliogr. 2012;103(7):588-95.
[52] MacLennan A, et al. Cochrane Database Syst Rev. 2001;(1):CD002978.
[53] MacLennan A, et al. Climacteric. 2001;4(1):58-74.
[54] NHS. "Treatment for menopause and perimenopause." NHS, 17 May 2022.